Role of RNF213 p.4810K variant in the development of intracranial arterial disease in patients treated with nilotinib

J Neurol Sci. 2020 Jan 15:408:116577. doi: 10.1016/j.jns.2019.116577. Epub 2019 Nov 9.

¹ Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
² Department of Cerebrovascular Medicine, Niigata City General Hospital, Niigata, Japan; Department of Neurology, Niigata City General Hospital, Niigata, Japan.
³ Department of Cerebrovascular Medicine, Niigata City General Hospital, Niigata, Japan.
⁴ Departments of Neurology, Niigata Prefectural Shibata Hospital, Niigata, Japan.
⁵ Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan.
⁶ Department of Hematology, Niigata City General Hospital, Niigata, Japan.
⁷ Department of Translational Research, Brain Research Institute, Niigata University, Niigata, Japan.
⁸ Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan. Electronic address: onodera@bri.niigata-u.ac.jp.

No abstract available

Keywords: Intracranial arterial stenosis; Nilotinib; RNF213.

Publication types